Electrocardiogram-Based Artificial Intelligence to Discriminate Cardioembolic Stroke and Stratify Risk of Atrial Fibrillation After Stroke
- PMID: 39193715
- PMCID: PMC11479813
- DOI: 10.1161/CIRCEP.124.012959
Electrocardiogram-Based Artificial Intelligence to Discriminate Cardioembolic Stroke and Stratify Risk of Atrial Fibrillation After Stroke
Keywords: anticoagulants; atrial fibrillation; deep learning; risk factors; stroke.
Conflict of interest statement
Dr Lubitz is employed at Novartis as of July 2022. Dr Lubitz previously received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. Dr Ellinor receives sponsored research support from Bayer AG, IBM Research, Bristol Myers Squibb, Pfizer, and Novo Nordisk; he has also served on advisory boards or consulted for MyoKardia and Bayer AG. Dr Anderson has received sponsored research support from Bayer AG. The other authors report no conflicts.
Figures
References
-
- Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens ACJW, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2:e000102. - PMC - PubMed
-
- Khurshid S, Li X, Ashburner JM, Lipsanopoulos ATT, Lee PR, Lin AK, Ko D, Ellinor PT, Schwamm LH, Benjamin EJ, et al. Usefulness of Rhythm Monitoring Following Acute Ischemic Stroke. Am J Cardiol. 2021;147:44–51. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
